163 related articles for article (PubMed ID: 20580355)
21. In vitro antimicrobial activity against Pseudomonas aeruginosa and acute oral toxicity of marine algae Gracilaria changii.
Sasidharan S; Darah I; Noordin MK
N Biotechnol; 2010 Sep; 27(4):390-6. PubMed ID: 20170762
[TBL] [Abstract][Full Text] [Related]
22. Purification and properties of an S-type pyocin, pyocin AP41.
Sano Y; Kageyama M
J Bacteriol; 1981 May; 146(2):733-9. PubMed ID: 6783626
[TBL] [Abstract][Full Text] [Related]
23. Molecular Structure and Functional Analysis of Pyocin S8 from Pseudomonas aeruginosa Reveals the Essential Requirement of a Glutamate Residue in the H-N-H Motif for DNase Activity.
Turano H; Gomes F; Domingos RM; Degenhardt MFS; Oliveira CLP; Garratt RC; Lincopan N; Netto LES
J Bacteriol; 2020 Oct; 202(21):. PubMed ID: 32817098
[TBL] [Abstract][Full Text] [Related]
24. Characterization of R-pyocin activity against Gram-positive pathogens for the first time with special focus on Staphylococcus aureus.
Mohamed AA; Elshawadfy AM; Amin G; Askora A
J Appl Microbiol; 2021 Dec; 131(6):2780-2792. PubMed ID: 33977611
[TBL] [Abstract][Full Text] [Related]
25. Serological and pyocin typing and antibiotic sensitivity of Pseudomonas aeruginosa strains.
Del Piano M; La Palombara P; Picci A; Nicosia R
Microbiologica; 1986 Apr; 9(2):253-8. PubMed ID: 3086671
[TBL] [Abstract][Full Text] [Related]
26. O serotype-independent susceptibility of Pseudomonas aeruginosa to lectin-like pyocins.
Ghequire MG; Dingemans J; Pirnay JP; De Vos D; Cornelis P; De Mot R
Microbiologyopen; 2014 Dec; 3(6):875-84. PubMed ID: 25224846
[TBL] [Abstract][Full Text] [Related]
27. [Screening of producers of bacteriocin-like substances active against Pseudomonas aeruginosa].
Balko AB; Avdeeva LV
Mikrobiol Z; 2012; 74(2):8-13. PubMed ID: 22686012
[TBL] [Abstract][Full Text] [Related]
28. Antimicrobial susceptibility of Pseudomonas aeruginosa from dogs and cats as well as Arcanobacterium pyogenes from cattle and swine as determined in the BfT-GermVet monitoring program 2004-2006.
Werckenthin C; Alesík E; Grobbel M; Lübke-Becker A; Schwarz S; Wieler LH; Wallmann J
Berl Munch Tierarztl Wochenschr; 2007; 120(9-10):412-22. PubMed ID: 17939456
[TBL] [Abstract][Full Text] [Related]
29. Level of resistance of clinical isolates of Pseudomonas aeruginosa as related to their susceptibility to phages and R-pyocins.
Legakis N; Koukoubanis N; Malliara K; Tumah H
Chemioterapia; 1987 Jun; 6(2 Suppl):200-1. PubMed ID: 3151342
[No Abstract] [Full Text] [Related]
30. Targeted Killing of Pseudomonas aeruginosa by Pyocin G Occurs via the Hemin Transporter Hur.
Atanaskovic I; Mosbahi K; Sharp C; Housden NG; Kaminska R; Walker D; Kleanthous C
J Mol Biol; 2020 Jun; 432(13):3869-3880. PubMed ID: 32339530
[TBL] [Abstract][Full Text] [Related]
31. In vitro antimicrobial activity of liposomal meropenem against Pseudomonas aeruginosa strains.
Drulis-Kawa Z; Gubernator J; Dorotkiewicz-Jach A; Doroszkiewicz W; Kozubek A
Int J Pharm; 2006 Jun; 315(1-2):59-66. PubMed ID: 16551496
[TBL] [Abstract][Full Text] [Related]
32. Susceptibility of Pseudomonas aeruginosa of various pyocin types to the newly synthesized ampicillin derivative, N-(6,7-difluoroquinolonyl)ampicillin.
Chen CH; Tsou TL; Chiang HY; Lee SH; Lee F; Lee JH; Wang TM; Liu YT
J Antimicrob Chemother; 1997 Mar; 39(3):325-30. PubMed ID: 9096181
[TBL] [Abstract][Full Text] [Related]
33. Azithromycin exhibits bactericidal effects on Pseudomonas aeruginosa through interaction with the outer membrane.
Imamura Y; Higashiyama Y; Tomono K; Izumikawa K; Yanagihara K; Ohno H; Miyazaki Y; Hirakata Y; Mizuta Y; Kadota J; Iglewski BH; Kohno S
Antimicrob Agents Chemother; 2005 Apr; 49(4):1377-80. PubMed ID: 15793115
[TBL] [Abstract][Full Text] [Related]
34. R-type pyocin is required for competitive growth advantage between Pseudomonas aeruginosa strains.
Heo YJ; Chung IY; Choi KB; Cho YH
J Microbiol Biotechnol; 2007 Jan; 17(1):180-5. PubMed ID: 18051371
[TBL] [Abstract][Full Text] [Related]
35. Characterization of Pseudomonas aeruginosa isolated from drinking water by serogrouping, phage sensitivity and pyocin pattern.
Kiss P; Lantos J; Lányi B; Fodré Z
Acta Microbiol Hung; 1985; 32(1):99-106. PubMed ID: 3929555
[TBL] [Abstract][Full Text] [Related]
36. Impact of FiuA Outer Membrane Receptor Polymorphism on the Resistance of
Latino L; Patin D; Chérier D; Touzé T; Pourcel C; Barreteau H; Mengin-Lecreulx D
J Bacteriol; 2019 Jul; 201(13):. PubMed ID: 30988031
[TBL] [Abstract][Full Text] [Related]
37. Lipopolysaccharide as shield and receptor for R-pyocin-mediated killing in Pseudomonas aeruginosa.
Köhler T; Donner V; van Delden C
J Bacteriol; 2010 Apr; 192(7):1921-8. PubMed ID: 20118263
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial resistance and minimum inhibitory concentrations of bacteria isolated from bustards in the United Arab Emirates.
Bailey TA; Silvanose C; Wernery U; Samour JH; Naldo J
Avian Dis; 1998; 42(4):690-7. PubMed ID: 9876837
[TBL] [Abstract][Full Text] [Related]
39. Dansyl chloride labeling of Pseudomonas aeruginosa treated with pyocin R1: change in permeability of the cell envelope.
Uratani Y
J Bacteriol; 1982 Feb; 149(2):523-8. PubMed ID: 6799489
[TBL] [Abstract][Full Text] [Related]
40. The pyocins of Pseudomonas aeruginosa.
Michel-Briand Y; Baysse C
Biochimie; 2002; 84(5-6):499-510. PubMed ID: 12423794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
